Roger Henriksson

24.3k citations
406 papers · 14.8k · 5 hit papers · h-index 53

Impact in

  • Genetics top 0.05%
    • Glioma Diagnosis and Treatment
    • Cancer, Hypoxia, and Metabolism
    • MicroRNA in disease regulation

Papers in

Roger Henriksson

399 papers receiving 14.5k citations

Roger Henriksson's Hit Papers

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours 2017 · 441 citations
4410+4+9Years since publication50010001.5k

Peers

Roger Henriksson
Comparison fields: 5 of 156
  • Genetics 4.5k
  • Cancer Research 2.1k
  • Oncology 2.7k
  • Pulmonary and Respiratory Medicine 2.6k
  • Neurology 1.1k
Replace Judith R. OʼFallon with:
Judith R. OʼFallon United States
Victor A. Levin United States
Jan C. Buckner United States
Gabriele Schackert Germany
Mark R. Gilbert United States
David Zagzag United States
Ho‐Keung Ng Hong Kong
Isabelle Salmon Belgium
Stephen E. Sallan United States
Kathleen R. Lamborn United States
Roger Henriksson relative to Judith R. OʼFallon United States Judith R. OʼFallon's profile →
Citations per field
00.5×10×16×
Judith R. OʼFallon · 1×
Citations per year

Countries citing papers authored by Roger Henriksson

Since Specialization
Citations

This map shows the geographic impact of Roger Henriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Henriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Henriksson more than expected).

Fields of papers citing papers by Roger Henriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Henriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Henriksson. The network helps show where Roger Henriksson may publish in the future.

Co-authors

The 25 scholars most cited alongside Roger Henriksson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roger Henriksson Line = papers co-authored together Roger Henriksson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 406 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Hit paper breakdown →
20141851
2
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Hit paper breakdown →
2012874
3
EANO guidelines for the diagnosis and treatment of meningiomas
Hit paper breakdown →
2016585
4
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Hit paper breakdown →
2014573
5
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
Hit paper breakdown →
2017441
6 2001306
7 2015276
8 2004234
9 1998226
10 2000215
11 1992211
12 2015210
13 2005206
14 2012199
15 2017183
16 2008152
17 2019135
18 2008130
19 2008128
20
The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
2001128

About Roger Henriksson

Roger Henriksson is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 406 papers that have together received 14.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (80 papers), Neuropeptides and Animal Physiology (29 papers), Effects of Radiation Exposure (21 papers), Cancer, Hypoxia, and Metabolism (21 papers), Cancer Treatment and Pharmacology (20 papers), Brain Metastases and Treatment (19 papers), Glycosylation and Glycoproteins Research (17 papers) and Salivary Gland Disorders and Functions (16 papers). The work is most often cited by research in Genetics (4.5k citations), Cancer Research (2.1k citations), Oncology (2.7k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Neurology (1.1k citations). Roger Henriksson has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Kjell Grankvist, Wolfgang Wick, Lars Franzén, Håkan Hedman, Björn Tavelin, Olivier Chinot, A. Tommy Bergenheim, Ryo Nishikawa, Frank Saran and Warren Mason. Their work appears in journals such as Acta Oncologica, Journal of Neuro-Oncology, Journal of Clinical Oncology, Neuro-Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact